发明名称 Stabilized prostaglandin formulation
摘要 A discrete solid orally deliverable pharmaceutical dosage form comprises a plurality of zones, wherein (a) at least one zone comprises an NSAID; (b) at least one zone, other than a zone comprising the NSAID, comprises HPMC having dispersed therein a prostaglandin type compound in a form of a substantially water-free solid dispersion; (c) the plurality of zones are spatially arranged such that, if there is only one NSAID-containing zone and one prostaglandin-containing zone, these zones are arranged other than as a core and mantle respectively separated by an enteric coating layer; and (d) the HPMC comprises a fraction having particle size smaller than about 53 mum, said fraction exhibiting, upon dissolution in C02-free purified water to form a 1% weight/volume solution, a pH not lower than about 4. An assay method is also provided for selecting suitable lots of HPMC for use in preparing such a dosage form.
申请公布号 US2005031690(A1) 申请公布日期 2005.02.10
申请号 US20040825397 申请日期 2004.04.15
申请人 PHARMACIA CORPORATION 发明人 ROHRS BRIAN R.;DOUGLAS SCOTT L.;HEIMLICH JOHN M.;MILLER JAMES F.;BURGESS GEORGE A.;ROLFE PHILIP J.
分类号 A61K9/14;(IPC1-7):A61K31/60;A61K31/557;A61K9/24;A61K9/28 主分类号 A61K9/14
代理机构 代理人
主权项
地址